Noticias de investigación
Ver artículos por meses y años
1–4 of 4 artículos
-
Drug May Boost Survival in Metastatic Breast Cancer (en inglés)
Women diagnosed with metastatic breast cancer that had stopped responding or failed to respond to other treatments lived 2 months longer when treated with Halavan (chemical name: eribulin) compared to ...
-
FDA Approves Drug for Pretreated Breast Cancer (en inglés)
The U.S. Food and Drug Administration (FDA) has approved a new chemotherapy medicine, Halaven (chemical name: eribulin), to treat metastatic breast cancer that already has been treated with other chemo...
-
ESMO: Eribulin Shows Benefit Across Subgroups (en inglés)
A study suggests that an experimental chemotherapy medicine called eribulin may be a good treatment option for various types of metastatic breast cancer that have stopped responding or failed to respon...
-
ASCO: Sea Sponge Drug Saves Lives in Metastatic Breast CA (en inglés)
A study suggests that an experimental chemotherapy medicine called eribulin may be a good treatment option for metastatic breast cancer that has stopped responding or failed to respond to other treatme...
1–4 of 4 artículos
